ORIEN cancer consortium taps HudsonAlpha for clinical trial sequencing support by Nick Paul Taylor Tuesday, September 13, 2016 A consortium of cancer centers has contracted HudsonAlpha Institute of Biotechnology to sequence 20,000 samples by 2019.
